Logo image of ALUMS.PA

Umanis (ALUMS.PA) Stock Fundamental Analysis

EPA:ALUMS - Euronext Paris - Matif - FR0013263878 - Common Stock - Currency: EUR

17.15  -0.01 (-0.06%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALUMS. ALUMS was compared to 73 industry peers in the IT Services industry. ALUMS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALUMS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

ALUMS had positive earnings in the past year.
ALUMS.PA Yearly Net Income VS EBIT VS OCF VS FCFALUMS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M

1.2 Ratios

Industry RankSector Rank
ROA 5.21%
ROE 13.94%
ROIC 10.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUMS.PA Yearly ROA, ROE, ROICALUMS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 10 20 30

1.3 Margins

Industry RankSector Rank
OM 8.58%
PM (TTM) 5.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALUMS.PA Yearly Profit, Operating, Gross MarginsALUMS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 20 40 60 80

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALUMS is creating some value.
The number of shares outstanding for ALUMS remains at a similar level compared to 1 year ago.
The debt/assets ratio for ALUMS has been reduced compared to a year ago.
ALUMS.PA Yearly Shares OutstandingALUMS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M
ALUMS.PA Yearly Total Debt VS Total AssetsALUMS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 2.81 indicates that ALUMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALUMS has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 2.81
ROIC/WACC1.56
WACC7.03%
ALUMS.PA Yearly LT Debt VS Equity VS FCFALUMS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 0.97 indicates that ALUMS may have some problems paying its short term obligations.
A Quick Ratio of 0.97 indicates that ALUMS may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
ALUMS.PA Yearly Current Assets VS Current LiabilitesALUMS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

ALUMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.02%.
ALUMS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.30% yearly.
ALUMS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.47%.
ALUMS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.91% yearly.
EPS 1Y (TTM)-9.02%
EPS 3Y4.18%
EPS 5Y-0.3%
EPS Q2Q%-64%
Revenue 1Y (TTM)14.47%
Revenue growth 3Y5.96%
Revenue growth 5Y9.91%
Sales Q2Q%21.4%

3.2 Future

ALUMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.10% yearly.
The Revenue is expected to grow by 5.31% on average over the next years.
EPS Next Y14.77%
EPS Next 2Y16.29%
EPS Next 3Y14.76%
EPS Next 5Y14.1%
Revenue Next Year12.97%
Revenue Next 2Y8.65%
Revenue Next 3Y7.08%
Revenue Next 5Y5.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALUMS.PA Yearly Revenue VS EstimatesALUMS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALUMS.PA Yearly EPS VS EstimatesALUMS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.86, the valuation of ALUMS can be described as rather expensive.
When comparing the Price/Earnings ratio of ALUMS to the average of the S&P500 Index (26.34), we can say ALUMS is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 16.49, the valuation of ALUMS can be described as correct.
The average S&P500 Price/Forward Earnings ratio is at 21.03. ALUMS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.86
Fwd PE 16.49
ALUMS.PA Price Earnings VS Forward Price EarningsALUMS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.05
ALUMS.PA Per share dataALUMS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ALUMS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALUMS's earnings are expected to grow with 14.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.68
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y14.76%

0

5. Dividend

5.1 Amount

ALUMS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Umanis

EPA:ALUMS (7/12/2022, 7:00:00 PM)

17.15

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap309.30M
Analysts40
Price Target17.44 (1.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 24.86
Fwd PE 16.49
P/S 1.26
P/FCF N/A
P/OCF N/A
P/B 3.36
P/tB N/A
EV/EBITDA 12.05
EPS(TTM)0.69
EY4.02%
EPS(NY)1.04
Fwd EY6.07%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.64
BVpS5.11
TBVpSN/A
PEG (NY)1.68
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.21%
ROE 13.94%
ROCE N/A
ROIC 10.98%
ROICexc N/A
ROICexgc 53.85%
OM 8.58%
PM (TTM) 5.22%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 2.81
F-Score5
WACC7.03%
ROIC/WACC1.56
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.02%
EPS 3Y4.18%
EPS 5Y-0.3%
EPS Q2Q%-64%
EPS Next Y14.77%
EPS Next 2Y16.29%
EPS Next 3Y14.76%
EPS Next 5Y14.1%
Revenue 1Y (TTM)14.47%
Revenue growth 3Y5.96%
Revenue growth 5Y9.91%
Sales Q2Q%21.4%
Revenue Next Year12.97%
Revenue Next 2Y8.65%
Revenue Next 3Y7.08%
Revenue Next 5Y5.31%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A